Shih, Ya-Chen Tina; Bekele, Nebiyou B.; Xu, Ying - In: PharmacoEconomics 25 (2007) 10, pp. 843-862
Introduction: Since their invention in the late 1980s and early 1990s, selective serotonin reuptake inhibitors (SSRIs) have become the primary form of pharmaceutical treatment for depression. As the patents of several top-selling SSRIs have expired or are soon to be expired, the SSRI market is...